Y-mAbs Therapeutics, Inc

YmAbs is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.

Business Model:

Revenue: $40M

Employees: 51-200

Detailed Y-mAbs Therapeutics, Inc Information

Geographic Data

Y-mAbs Therapeutics, Inc headquarters map

Address: 230 Park Avenue

City: New York

State: NY

Zip: 10169

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$115M

Raised Total:

$146M

Metrics

3,305,936Website Global Rank

3,755Website Monthly Traffic

Twitter Followers

Description

YmAbs is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.

Contact Phone:
+12128479841

Contact Email:

Y-mAbs Therapeutics, Inc went public on 9/20/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
9/20/2018

Ticker Symbol:
YMAB

IPO Price:
$16/share

Amount Raised:
$96M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research